Maternal diet-induced obesity programs cardiovascular dysfunction in adult male mouse offspring independent of current body weight

Endocrinology (United States)

Volumn 155, Issue 10, 2014, Pages 3970-3980

  Blackmore, Heather L ^a   Niu, Youguo ^b   Fernandez Twinn, Denise S ^a   Tarry Adkins, Jane L ^a   Giussani, Dino A ^b   Ozanne, Susan E ^a  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; CARBOHYDRATE; CHOLESTEROL; FATTY ACID; MUSCARINIC M2 RECEPTOR; MYOSIN HEAVY CHAIN BETA; SATURATED FATTY ACID; TRIACYLGLYCEROL;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE EXPRESSION; HEART CONTRACTION; HEART FUNCTION; HEART MUSCLE CELL; HEART VENTRICLE HYPERTROPHY; HEART WEIGHT; HISTOLOGY; LACTATION; LOW FAT DIET; MALE; MATERNAL NUTRITION; MATERNAL OBESITY; MORPHOMETRICS; MOUSE; NONHUMAN; PREGNANCY; PROGENY; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEREOLOGY; SYSTOLIC DYSFUNCTION; ANIMAL; C57BL MOUSE; CARDIOVASCULAR DISEASES; CELL CULTURE; COMPLICATION; DIET; EMBRYO DEVELOPMENT; EMBRYOLOGY; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE;

ANIMALS; BODY WEIGHT; CARDIOVASCULAR DISEASES; CELLS, CULTURED; DIET; EMBRYONIC DEVELOPMENT; FEMALE; MATERNAL NUTRITIONAL PHYSIOLOGICAL PHENOMENA; MICE; MICE, INBRED C57BL; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 84907200626     PISSN: 00137227     EISSN: 19457170     Source Type: Journal    
DOI: 10.1210/en.2014-1383     Document Type: Article

References (58)

1. Heslehurst N, Rankin J, Wilkinson JR, Summerbell CD. A nationally representative study of maternal obesity in England, UK: Trends in incidence and demographic inequalities in 619 323 births, 1989-2007. Int J Obes (Lond). 2010;34(3):420-428.
2. Crane JM, Murphy P, Burrage L, Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy. J Obstet Gynaecol Can. 2013;35(7):606-611.
3. Athukorala C, Rumbold AR, Willson KJ, Crowther CA. The risk of adverse pregnancy outcomes in women who are overweight or obese. BMC Pregnancy Childbirth. 2010;10:56.
4. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in utero and early-life conditions on adult health and disease. N Engl J Med. 2008;359(1):61-73.
5. Giussani DA, Davidge ST. Developmental programming of cardiovascular disease by prenatal hypoxia. J Dev Orig Health Dis. 2013; 6(5):328-337.
6. Reynolds RM, Allan KM, Raja EA, et al. Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: Follow-up of 1 323 275 person years. BMJ. 2013; 347:f4539.
7. Forsén T, Eriksson JG, Tuomilehto J, Teramo K, Osmond C, Barker DJ. Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: Follow up study. BMJ. 1997;315(7112): 837-840.
8. Liang C, Oest ME, Prater MR. Intrauterine exposure to high saturated fat diet elevates risk of adult-onset chronic diseases in C57BL/6 mice. Birth Defects Res B Dev Reprod Toxicol. 2009;86(5):377-384.
9. Guberman C, Jellyman JK, Han G, Ross MG, Desai M. Maternal high-fat diet programs rat offspring hypertension and activates the adipose renin-angiotensin system. Am J Obstet Gynecol. 2013; 209(3):262.e261-e268.
10. Ghosh P, Bitsanis D, Ghebremeskel K, Crawford MA, Poston L. Abnormal aortic fatty acid composition and small artery function in offspring of rats fed a high fat diet in pregnancy. J Physiol. 2001; 533(Pt 3):815-822.
11. Bringhenti I, Moraes-Teixeira JA, Cunha MR, et al. Maternal obesity during the preconception and early life periods alters pancreatic development in early and adult life in male mouse offspring. PLoS One. 2013;8(1):e55711.
12. Samuelsson AM, Matthews PA, Argenton M, et al. Diet-induced obesity in female mice leads to offspring hyperphagia, adiposity, hypertension, and insulin resistance: A novel murine model of developmental programming. Hypertension. 2008;51(2):383-392.
13. Fernandez-Twinn DS, Blackmore HL, Siggens L, et al. The programming of cardiac hypertrophy in the offspring by maternal obesity is associated with hyperinsulinemia, AKT, ERK, and mTOR activation. Endocrinology. 2012;153(12):5961-5971.
14. Fan X, Turdi S, Ford SP, et al. Influence of gestational overfeeding on cardiac morphometry and hypertrophic protein markers in fetal sheep. J Nutr Biochem. 2011;22(1):30-37.
15. Wang J, Ma H, Tong C, et al. Overnutrition and maternal obesity in sheep pregnancy alter the JNK-IRS-1 signaling cascades and cardiac function in the fetal heart. FASEB J. 2010;24(6):2066-2076.
16. Han J, Xu J, Epstein PN, Liu YQ. Long-term effect of maternal obesity on pancreatic beta cells of offspring: Reduced beta cell adaptation to high glucose and high-fat diet challenges in adult female mouse offspring. Diabetologia. 2005;48(9):1810-1818.
17. Fan L, Lindsley SR, Comstock SM, et al. Maternal high-fat diet impacts endothelial function in nonhuman primate offspring. Int J Obes (Lond). 2013;37(2):254-262.
18. Moreira AS, Teixeira Teixeira M, da Silveira Osso F, et al. Left ventricular hypertrophy induced by overnutrition early in life. Nutr Metab Cardiovasc Dis. 2009;19(11):805-810.
19. Elahi MM, Cagampang FR, Mukhtar D, Anthony FW, Ohri SK, Hanson MA. Long-term maternal high-fat feeding from weaning through pregnancy and lactation predisposes offspring to hypertension, raised plasma lipids and fatty liver in mice. Br J Nutr. 2009; 102(4):514-519.
20. Samuelsson AM, Morris A, Igosheva N, et al. Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. Hypertension. 2010;55(1):76-82.
21. Artham SM, Lavie CJ, Milani RV, Ventura HO. Obesity and hypertension, heart failure, and coronary heart disease-risk factor, paradox, and recommendations for weight loss. Ochsner J. 2009;9(3): 124-132.
22. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67(5):968-977.
23. Giussani DA, Camm EJ, Niu Y, et al. Developmental programming of cardiovascular dysfunction by prenatal hypoxia and oxidative stress. PLoS One. 2012;7(2):e31017.
24. Chelu MG, Sarma S, Sood S, et al. Calmodulin kinase II-mediated sarcoplasmic reticulum Ca2 leak promotes atrial fibrillation in mice. J Clin Invest. 2009;119(7):1940-1951.
25. Niu Y, Herrera EA, Evans RD, Giussani DA. Antioxidant treatment improves neonatal survival and prevents impaired cardiac function at adulthood following neonatal glucocorticoid therapy. J Physiol. 2013;591(Pt 20):5083-5093.
26. Kuwahara K, Nishikimi T, Nakao K. Transcriptional regulation of the fetal cardiac gene program. J Pharmacol Sci. 2012;119(3):198-203.
27. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 1991;68(6):1742-1750.
28. Krenz M, Robbins J. Impact of beta-myosin heavy chain expression on cardiac function during stress. J Am Coll Cardiol. 2004;44(12): 2390-2397.
29. Tardiff JC, Hewett TE, Factor SM, Vikstrom KL, Robbins J, LeinwandLA. Expression of the beta (slow)-isoform ofMHCin the adult mouse heart causes dominant-negative functional effects. Am J Physiol Heart Circ Physiol. 2000;278(2):H412-419.
30. Sakata Y, Ohtani T, Takeda Y, Yamamoto K, Mano T. Left ventricular stiffening as therapeutic target for heart failure with preserved ejection fraction. Circ J. 2013;77(4):886-892.
31. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. JAmColl Cardiol. 1995;26(5):1257-1263.
32. WooAY,Xiao RP. Adrenergic receptor subtype signaling in heart: From bench to bedside. Acta Pharmacol Sin. 2012;33(3):335-341.
33. Philipp M, Hein L. Adrenergic receptor knockout mice: Distinct functions of 9 receptor subtypes. Pharmacol Ther. 2004;101(1): 65-74.
34. Rohrer DK, Desai KH, Jasper JR, et al. Targeted disruption of the mouse beta1-adrenergic receptor gene: Developmental and cardiovascular effects. Proc Natl Acad SciUSA. 1996;93(14):7375-7380.
35. de Tombe PP. Cardiac myofilaments: Mechanics and regulation. J Biomech. 2003;36(5):721-730.
36. Day SM, Westfall MV, Metzger JM. Tuning cardiac performance in ischemic heart disease and failure by modulating myofilament function. J Mol Med (Berl). 2007;85(9):911-921.
37. Huang X, Pi Y, Lee KJ, et al. Cardiac troponin I gene knockout: A mouse model of myocardial troponin I deficiency. Circ Res. 1999; 84(1):1-8.
38. Kawase Y, Hajjar RJ. The cardiac sarcoplasmic/endoplasmic reticulum calcium ATPase: A potent target for cardiovascular diseases. Nat Clin Pract Cardiovasc Med. 2008;5(9):554-565.
39. Distefano G, Sciacca P. Molecular pathogenesis of myocardial remodeling and new potential therapeutic targets in chronic heart failure. Ital J Pediatr. 2012;38:41.
40. McCullough PA, Nowak RM, McCord J, et al. B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: Analysis from Breathing Not Properly (BNP) Multinational Study. Circulation. 2002;106(4):416-422.
41. Nishii M, Inomata T, Takehana H, et al. Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure. J Am Coll Cardiol. 2008;51(24):2329-2335.
42. Nishikimi T, Maeda N, Matsuoka H. The role of natriuretic peptides in cardioprotection. Cardiovasc Res. 2006;69(2):318-328.
43. Bishopric NH, Simpson PC, Ordahl CP. Induction of the skeletal alpha-actin gene in alpha 1-adrenoceptor-mediated hypertrophy of rat cardiac myocytes. J Clin Invest. 1987;80(4):1194-1199.
44. Adachi S, Ito H, Tamamori M, Tanaka M, Marumo F, Hiroe M. Skeletal and smooth muscle alpha-actin mRNA in endomyocardial biopsy samples of dilated cardiomyopathy patients. Life Sci. 1998; 63(20):1779-1791.
45. Hewett TE, Grupp IL, Grupp G, Robbins J. Alpha-skeletal actin is associated with increased contractility in the mouse heart. Circ Res. 1994;74(4):740-746.
46. Clément S, Chaponnier C, Gabbiani G. A subpopulation of cardiomyocytes expressing alpha-skeletal actin is identified by a specific polyclonal antibody. Circ Res. 1999;85(10):e51-58.
47. Holubarsch C, Goulette RP, Litten RZ, Martin BJ, Mulieri LA, Alpert NR. The economy of isometric force development, myosin isoenzyme pattern and myofibrillar ATPase activity in normal and hypothyroid rat myocardium. Circ Res. 1985;56(1):78-86.
48. Chen Y, Somji A, Yu X, Stelzer JE. Altered in vivo left ventricular torsion and principal strains in hypothyroid rats.AmJ Physiol Heart Circ Physiol. 2010;299(5):H1577-1587.
49. Morkin E. Regulation of myosin heavy chain genes in the heart. Circulation. 1993;87(5):1451-1460.
50. Somura F, Izawa H, Iwase M, et al. Reduced myocardial sarcoplasmic reticulum Ca(2)-ATPase mRNA expression and biphasic force-frequency relations in patients with hypertrophic cardiomyopathy. Circulation. 2001;104(6):658-663.
51. Stüdeli R, Jung S, Mohacsi P, et al. Diastolic dysfunction in human cardiac allografts is related with reduced SERCA2a gene expression. Am J Transplant. 2006;6(4):775-782.
52. Talukder MA, Kalyanasundaram A, Zuo L, et al. Is reduced SERCA2a expression detrimental or beneficial to postischemic cardiac function and injury? Evidence from heterozygous SERCA2a knockout mice. Am J Physiol Heart Circ Physiol. 2008;294(3): H1426-1434.
53. Zakhary DR, Moravec CS, Stewart RW, Bond M. Protein kinase A (PKA)-dependent troponin-I phosphorylation and PKA regulatory subunits are decreased in human dilated cardiomyopathy. Circulation. 1999;99(4):505-510.
54. van der Velden J, Papp Z, Zaremba Ret al. Increased Ca2-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res. 2003;57(1):37-47.
55. Salem R, Denault AY, Couture P, et al. Left ventricular end-diastolic pressure is a predictor of mortality in cardiac surgery independently of left ventricular ejection fraction. Br J Anaesth. 2006;97(3):292-297.
56. Olshansky B, Sabbah HN, Hauptman PJ, Colucci WS. Parasympathetic nervous system and heart failure: Pathophysiology and potential implications for therapy. Circulation. 2008;118(8):863-871.
57. Brodde OE, MichelMC.Adrenergic and muscarinic receptors in the human heart. Pharmacol Rev. 1999;51(4):651-690.
58. Streicher JM, Ren S, Herschman H, Wang Y. MAPK-activated protein kinase-2 in cardiac hypertrophy and cyclooxygenase-2 regulation in heart. Circ Res. 2010;106(8):1434-1443.